| |
Company
Roster
|
|
Total
Insiders : |
35 |
|
|
|
Total
Direct Shares :
|
8,488,936 |
|
|
Total
Indirect Shares :
|
22,703,737 |
| |
%
Held by Insiders:
|
56.37% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Abingworth Llp |
10% Owner |
|
0 |
2022-01-31 |
1,314,127 |
| Aggarwal Gaurav |
Director |
2020-01-29 |
0 |
2022-07-01 |
0 |
| Allen Andrew R |
Director, 10% Owner |
2022-07-01 |
0 |
2018-12-10 |
0 |
| Anderson Keith Edward |
|
|
0 |
|
0 |
| Ashiya Mona |
Director, 10% Owner |
2020-01-29 |
0 |
2022-07-01 |
0 |
| Cha Albert |
Director |
2015-07-21 |
0 |
2015-07-21 |
2,438,270 |
| Chapman Wendy |
SVP Clinical Operations |
2016-03-22 |
0 |
2016-01-22 |
0 |
| Collard Craig A |
Director |
2022-07-01 |
0 |
2021-11-23 |
0 |
| Dilly Stephen George |
CEO and President, Director |
2022-07-01 |
0 |
2021-05-19 |
0 |
| Enright Patrick G |
10% Owner |
2020-01-29 |
0 |
2022-01-25 |
1,964,771 |
| Estes Daniel |
|
|
0 |
|
0 |
| Glover Nicholas |
CEO and President, Director |
2016-01-15 |
0 |
2016-01-15 |
0 |
| Hassig Christian |
|
|
0 |
|
0 |
| Heron Patrick J |
10% Owner |
2017-02-14 |
8,112,121 |
|
0 |
| Klencke Barbara |
Chief Medical Officer |
2022-07-01 |
0 |
2022-07-01 |
0 |
| Kowalski Mark |
|
|
0 |
|
0 |
| Longitude Prime Fund, L.p. |
10% Owner |
2022-02-02 |
0 |
2022-04-27 |
8,015 |
| Lovejoy Chandra D |
SVP of Reg. Affairs & Quality |
2016-01-12 |
0 |
|
0 |
| Messmann Richard A |
Officer |
2015-07-15 |
40,052 |
|
0 |
| Orbimed Capital Gp Vii Llc |
Director, 10% Owner |
2022-07-01 |
0 |
2022-07-01 |
0 |
| Orbimed Capital Llc |
Director, 10% Owner |
2020-01-29 |
0 |
2020-01-29 |
1,477,320 |
| Orbimed Genesis Gp Llc |
Director, 10% Owner |
2022-01-26 |
0 |
2022-01-26 |
226,704 |
| Orbimed Private Investments V, Lp |
Director |
2015-07-21 |
0 |
2015-07-21 |
1,989,949 |
| Parfet Donald R |
Director |
2018-01-04 |
77,235 |
2018-01-04 |
243,978 |
| Pelzer Robert |
|
|
0 |
|
0 |
| Richardson Joshua |
Director, 10% Owner |
2020-01-29 |
0 |
2022-02-02 |
2,139,771 |
| Rodigueza Wendi |
Chief Scientific Officer |
2016-01-22 |
156,276 |
|
0 |
| Sinclair Andrew |
Director |
|
0 |
2022-07-01 |
0 |
| Thompson Peter A |
Director |
2015-07-21 |
0 |
2015-07-21 |
1,989,949 |
| Thomson Mary Christina |
General Counsel, CCO & Secy |
2022-04-04 |
0 |
2022-01-26 |
0 |
| Topper James N |
Director, 10% Owner |
2015-07-21 |
0 |
2017-02-14 |
8,112,121 |
| Turner William D. |
Chief Reg & Tech Ops Officer |
2022-04-06 |
0 |
2022-01-26 |
0 |
| Vitangcol Alvin |
Director |
2015-07-21 |
0 |
2015-07-21 |
798,762 |
| Vivo Ventures Vii Affiliates Fund, L.p. |
Director, 10% Owner |
2015-07-21 |
0 |
2022-07-01 |
0 |
| You Angie |
Officer |
2015-07-15 |
103,252 |
|
0 |
|
